4Dmedical Valuation
| 4DX Stock | 0.46 0.01 2.22% |
4Dmedical is overvalued. 4Dmedical shows a prevailing Real Value of USD0.41 per share. The current price of the firm is USD0.46. Our model approximates the value of 4Dmedical from analyzing the firm fundamentals such as operating margin of (7.55) %, and Return On Equity of -0.51 as well as examining its technical indicators and probability of bankruptcy.
Price Book 2.6695 | Enterprise Value 163.9 M | Enterprise Value Ebitda (7.29) | Price Sales 50.4325 | Enterprise Value Revenue 53.7276 |
Overvalued
Today
Please note that 4Dmedical's price fluctuation is out of control at this time. Calculation of the real value of 4Dmedical is based on 3 months time horizon. Increasing 4Dmedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
4Dmedical's intrinsic value may or may not be the same as its current market price of 0.46, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.46 | Real 0.41 | Hype 0.45 |
The intrinsic value of 4Dmedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence 4Dmedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of 4Dmedical helps investors to forecast how 4Dmedical stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of 4Dmedical more accurately as focusing exclusively on 4Dmedical's fundamentals will not take into account other important factors: 4Dmedical Cash |
|
4Dmedical Total Value Analysis
4Dmedical is presently anticipated to have takeover price of 163.85 M with market capitalization of 189.34 M, debt of 5.12 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the 4Dmedical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
163.85 M | 189.34 M | 5.12 M |
4Dmedical Investor Information
About 22.0% of the company shares are owned by insiders or employees . The book value of 4Dmedical was presently reported as 0.17. The company recorded a loss per share of 0.1. 4Dmedical had not issued any dividends in recent years. 4Dmedical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.4Dmedical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. 4Dmedical has an asset utilization ratio of 3.13 percent. This implies that the Company is making USD0.0313 for each dollar of assets. An increasing asset utilization means that 4Dmedical is more efficient with each dollar of assets it utilizes for everyday operations.4Dmedical Ownership Allocation
4Dmedical holds a total of 411.6 Million outstanding shares. 4Dmedical retains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.4Dmedical Profitability Analysis
The company reported the revenue of 3.75 M. Net Loss for the year was (35.98 M) with profit before overhead, payroll, taxes, and interest of 684.43 K.About 4Dmedical Valuation
The stock valuation mechanism determines 4Dmedical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of 4Dmedical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of 4Dmedical. We calculate exposure to 4Dmedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of 4Dmedical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 3.5 M | 3.7 M |
Additional Tools for 4Dmedical Stock Analysis
When running 4Dmedical's price analysis, check to measure 4Dmedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4Dmedical is operating at the current time. Most of 4Dmedical's value examination focuses on studying past and present price action to predict the probability of 4Dmedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4Dmedical's price. Additionally, you may evaluate how the addition of 4Dmedical to your portfolios can decrease your overall portfolio volatility.